Wynzora

Wynzora combines betamethasone and calcipotriol for topical treatment of plaque psoriasis. This corticosteroid and vitamin D3 analog blend reduces inflammation and skin cell overgrowth. Ideal for adults seeking relief from psoriasis symptoms. Wynzora cream offers a convenient once-daily application.

Wynzora cream is used to treat plaque psoriasis in adults. It combines two active ingredients to reduce redness, scaling, and itching associated with psoriasis. The medication helps slow skin cell growth and decreases inflammation. Wynzora is designed for use on affected skin areas as directed by a healthcare provider.

Wynzora works by reducing inflammation and slowing the rapid growth of skin cells. Users may notice reduced redness and scaling within a few weeks of consistent use. The cream is formulated to provide moisturizing benefits while addressing psoriasis symptoms. Individual results may vary based on skin type and condition severity.

Wynzora is for external use only and should not be applied to the face, groin, or underarms unless directed by a doctor. Avoid contact with eyes, mouth, or broken skin. Wash hands after application and avoid covering treated areas with bandages unless advised. Keep out of reach of children. Consult a healthcare provider if irritation occurs.

Avoid using Wynzora with other topical medications containing corticosteroids or vitamin D analogs. Inform your healthcare provider about all medications, supplements, and skin products you use. Alcohol-based products may increase skin dryness or irritation. No significant systemic interactions are reported with topical use.